Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT03059979
What this trial is testing

The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )

Who this might be right for
Systemic SclerosisRaynaud Phenomena
Radboud University Medical Center 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07691970
What this trial is testing

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Who this might be right for
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
AstraZeneca 1,072
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06821659
What this trial is testing

Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Inflammatory Myopathies+2 more
Peking University Third Hospital 9
Not applicableLooking for participantsNCT06894654
What this trial is testing

DERMATOMICS: Identifying Regulators of Skin Homeostasis

Who this might be right for
Systemic Sclerosis (SSc)
Relation Therapeutics 500
Not applicableWithdrawnNCT01639573
What this trial is testing

Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis

Who this might be right for
Scleroderma
Children's Hospital Los Angeles
Very early researchNot Yet RecruitingNCT07158996
What this trial is testing

Cizutamig in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)
Ruijin Hospital 10
Early research (Phase 1)Study completedNCT01284322
What this trial is testing

Fresolimumab In Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Boston University 18
Early research (Phase 1)Looking for participantsNCT07284797
What this trial is testing

Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases

Who this might be right for
HealthyIdiopathic Inflammatory MyopathiesSystemic Sclerosis+1 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05270668
What this trial is testing

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisInterstitial Lung Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 154
Not applicableNot Yet RecruitingNCT06287125
What this trial is testing

Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Sclerosis and Systemic Lupus Erythematous
Assiut University 95
Testing effectiveness (Phase 2)Study completedNCT01670565
What this trial is testing

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 20
Testing effectiveness (Phase 2)WithdrawnNCT03679845
What this trial is testing

Study to Assess Sarilumab in Halting Progression of Morphea

Who this might be right for
Morphea, Plaque Form
Massachusetts General Hospital
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Not applicableLooking for participantsNCT04265144
What this trial is testing

Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Who this might be right for
SclerodermaSystemic Sclerosis
University Hospital, Bordeaux 500
Not applicableWithdrawnNCT05177471
What this trial is testing

Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France
Not applicableStudy completedNCT01762449
What this trial is testing

Morbidity and Mortality Follow Up for the Scleroderma Lung Study

Who this might be right for
Scleroderma
Duke University 158
Not applicableLooking for participantsNCT07723872
What this trial is testing

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more
Hospital de Granollers 100
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Testing effectiveness (Phase 2)Study completedNCT02921971
What this trial is testing

Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 97
Not applicableUnknownNCT06373081
What this trial is testing

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Shanghai Changzheng Hospital 6
Next Page